➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Medtronic
AstraZeneca
Express Scripts
Dow

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021132


Email this page to a colleague

« Back to Dashboard

NDA 021132 describes ZYVOX, which is a drug marketed by Pfizer and is included in three NDAs. It is available from four suppliers. There are two patents protecting this drug and four Paragraph IV challenges. Additional details are available on the ZYVOX profile page.

The generic ingredient in ZYVOX is linezolid. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the linezolid profile page.
Summary for 021132
Tradename:ZYVOX
Applicant:Pfizer
Ingredient:linezolid
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 021132
Medical Subject Heading (MeSH) Categories for 021132
Suppliers and Packaging for NDA: 021132
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZYVOX linezolid FOR SUSPENSION;ORAL 021132 NDA Pharmacia & Upjohn Company LLC 0009-5136 0009-5136-01 240 mL in 1 BOTTLE (0009-5136-01)
ZYVOX linezolid FOR SUSPENSION;ORAL 021132 NDA AUTHORIZED GENERIC Greenstone LLC 59762-1308 59762-1308-1 150 mL in 1 BOTTLE (59762-1308-1)
Paragraph IV (Patent) Challenges for 021132
Tradename Dosage Ingredient NDA Submissiondate
ZYVOX FOR SUSPENSION;ORAL linezolid 021132 2009-08-03

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength100MG/5ML
Approval Date:Apr 18, 2000TE:ABRLD:Yes
Patent:  Try Before You BuyPatent Expiration:Jul 29, 2021Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Merck
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.